ChemoCentryx
CCXI
#3578
Rank
ยฃ2.85 B
Marketcap
ยฃ39.73
Share price
0.00%
Change (1 day)
33.70%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -ยฃ1.45

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -ยฃ1.44. In 2021 the company made an earnings per share (EPS) of -ยฃ1.44 a decrease over its 2020 EPS that were of -ยฃ0.62.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-ยฃ1.450.22%
2021-ยฃ1.44133.33%
2020-ยฃ0.62-16.49%
2019-ยฃ0.7427.63%
2018-ยฃ0.58-305.41%
2017ยฃ0.28-142.53%
2016-ยฃ0.66-19.44%
2015-ยฃ0.83-0%
2014-ยฃ0.8313.68%
2013-ยฃ0.73-16.67%
2012-ยฃ0.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.54-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.47-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.28-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.80-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.76-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.45-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.20-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel